U-CyTech biosciences
PrivateLast Round
Early Funding
Sep 13, 2024
Total Funding Raised
$9.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
U-CyTech biosciences is a biotechnology company that develops, produces, and sells innovative cytokine ELISA, ELISPOT, and FluoroSpot assays for research use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
U-CyTech biosciences Comparables
Compare U-CyTech biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mabtech AB | 84% | |
| VION Biosciences | 83% | |
| Neomend | 79% | |
U-CyTech biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 13, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 1610% MoM, reaching 1.3K.
- Oct 15, 2023
Grew 175% QoQ from 4 to 11 employees.
U-CyTech biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about U-CyTech biosciences's valuation, stock price, and market status.